GLP-1 research peptide
A research-grade synthetic peptide designed as a glucagon-like peptide-1 (GLP-1) receptor agonist. Used in controlled in vitro and preclinical models to study GLP-1 receptor signaling, incretin hormone pathways, and related metabolic mechanisms. This page is informational (RUO); it does not describe clinical use or outcomes.
Current value
$79.00 USD
Certified purity
≥99% (per CoA methodology)
SEMA peptide for sale is a research-grade, lyophilized peptide supplied for controlled laboratory research involving GLP-1 receptor assay systems, peptide characterization, and COA-based batch review. For laboratory research use only. Not intended for use in humans or animals.
Studio product image of Peptide Researches SEMA 10 MG featuring the branded box, QR code, purity details, and vial for laboratory research catalog pages.
≥99% (per CoA methodology)
Structure & identity
Key identity fields aligned with the product page; always verify against your batch CoA.
Molecular formula
Identity per product specifications — confirm on your lot CoA.
Purity
≥99% (HPLC verified)
Form
Lyophilized powder
Available sizes
5mg, 10mg, 15mg, 20mg
Semaglutide is a synthetic peptide designed to activate the glucagon-like peptide-1 (GLP-1) receptor, a G protein-coupled receptor involved in glucose homeostasis and metabolic regulation. In research contexts, it is used to investigate GLP-1 receptor signaling cascades, downstream pathway activation, and receptor-level interactions in controlled laboratory models.
Common research applications include mechanistic signaling studies examining cAMP production, PKA activation, and CREB phosphorylation following GLP-1R engagement. Studies also explore metabolic pathway modulation, insulin secretion pathways, and receptor desensitization kinetics in appropriate cell-based assays.
As an incretin mimetic, semaglutide serves as a tool compound for investigating incretin hormone biology, receptor pharmacology, and structure-activity relationships. Your research program should validate receptor expression, assay conditions, and pharmacological controls independently of vendor materials.
Analytical verification
Release testing typically includes reversed-phase HPLC analysis to confirm identity and purity (≥99% typical). Each batch includes a Certificate of Analysis (CoA) documenting chromatography data, mass spectrometry confirmation, and acceptance criteria. Request the CoA for your specific lot to review analytical methods and batch traceability—do not infer purity from page copy alone.
Download CoA (PDF)Lyophilized research materials stay analytically useful when storage temperature, light exposure, and reconstitution follow your lot certificate of analysis and institutional SOPs—not generic web copy.
Store lyophilized semaglutide frozen at −20 °C for long-term stability. After reconstitution with appropriate sterile diluent, refrigerate at 2–8 °C and minimize hold times. Follow your lot-specific CoA for batch storage recommendations.
Batch-specific guidanceProtect from prolonged UV exposure and bright light. Use amber vials or foil wrap to reduce photodegradation risk during storage and handling in laboratory environments.
Batch-specific guidanceReconstitute gently along the vial wall with suitable sterile diluent solution (e.g., bacteriostatic water); avoid aggressive vortexing or shaking. Aliquot reconstituted material to limit freeze–thaw cycles and maintain peptide integrity throughout your study.
Batch-specific guidanceFor laboratory research use only (RUO). Not for human consumption, medical treatment, veterinary use, or diagnostic purposes. This material is not a pharmaceutical drug or compounded medication. Handle only by qualified personnel in appropriate laboratory environments. Always follow institutional protocols, local regulations, and the manufacturer CoA for your specific batch.
These authoritative sources provide context for GLP-1 research planning, incretin biology literature, and scientific methodology. Always verify material claims and analytical data against your specific batch documentation.
Primary literature index for GLP-1 receptor research and incretin biology.
Regulatory context for approved GLP-1 drugs (not applicable to research materials).
National institute resources for metabolic and diabetes-related research.
High-level research ethics and public health framing.
Structured for FAQ rich results. Confirm all material claims against your lot CoA.
Access live pricing, quantity bundles, variant selection, and detailed fulfillment policies.
All research-grade materials ship with batch-specific CoA documentation.
Ships worldwide • Research use only • Secure checkout
